# RTGN (Retinalgenix Technologies Inc.) - SEC EDGAR Financial Statements

> Retinalgenix Technologies Inc. reported $4.3K in total assets and a net loss of $1.95M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/RTGN
- Markdown: https://convexityos.com/fundamentals/RTGN.md
- SEC CIK: 0001836295
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001836295&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -- | Operating profit |
| Net Income | FY 2025 | -$1.95M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.10 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $5 | Total debt: $5.1K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $83K | $373K | $524K | $809K | $680K | $432K |
| Total Operating Expenses | $2.42M | $4.32M | $2.09M | $3.91M | $2.18M | $2.08M |
| Interest Expense | $4.0K | $3.8K | $3.8K | $5.1K | $2.6K | -- |
| **Net Income** | -$2.43M | -$4.32M | -$2.09M | -$3.91M | -$2.18M | -$2.08M |
| Basic EPS | -$0.13 | -$0.24 | -$0.12 | -$0.25 | -$0.05 | -$0.05 |
| **Diluted EPS** | -$0.13 | -$0.24 | -$0.12 | -$0.25 | -$0.05 | -$0.05 |
| Basic Shares Outstanding | 18.6M | 17.9M | 17.4M | 15.6M | 41.2M | 39.7M |
| Diluted Shares Outstanding | 18.6M | 17.9M | 17.4M | 15.6M | 41.2M | 39.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $112K | $66K | $117K | $35K | $20K | $14K | $13K | $104K |
| Total Operating Expenses | $432K | $303K | $589K | $622K | $568K | $648K | $586K | $866K |
| Interest Expense | $1.5K | $4.0K | $1.3K | $1.1K | $958 | $1.1K | $909 | $960 |
| **Net Income** | -$433K | -$307K | -$590K | -$623K | -$569K | -$649K | -$587K | -$867K |
| Basic EPS | -$0.02 | -$0.02 | -$0.03 | -- | -$0.03 | -$0.03 | -$0.03 | -- |
| **Diluted EPS** | -$0.02 | -$0.02 | -$0.03 | -- | -$0.03 | -$0.03 | -$0.03 | -- |
| Basic Shares Outstanding | 19.1M | 18.8M | 18.8M | -- | 18.6M | 18.3M | 18.5M | -- |
| Diluted Shares Outstanding | 19.1M | 18.8M | 18.8M | -- | 18.6M | 18.3M | 18.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $15K | $6.1K | $0 | $38 | $4.9K | $2.2K |
| **Cash & Short-Term Investments** | $15K | $6.1K | $0 | $38 | $4.9K | $2.2K |
| **Total Current Assets** | $15K | $6.1K | $0 | $38 | $4.9K | $61K |
| Property, Plant & Equipment, Net | -- | $56 | $156 | $256 | -- | -- |
| **Total Non-Current Assets** | $6.3K | $8.9K | $156 | $256 | $0 | $0 |
| **Total Assets** | $21K | $15K | $156 | $294 | $4.9K | $61K |
| Accounts Payable | -- | -- | -- | -- | $251K | $141K |
| **Total Current Liabilities** | $2.32M | $1.47M | $1.41M | -- | -- | -- |
| **Total Non-Current Liabilities** | $3.7K | $6.5K | $0 | -- | -- | -- |
| **Total Liabilities** | $2.32M | $1.48M | $1.41M | $1.07M | $470K | $141K |
| **Total Debt (incl. Leases)** | $6.5K | $7.5K | -- | -- | -- | -- |
| Common Stock | $1.9K | $1.9K | $1.8K | $1.8K | $1.4K | $4.1K |
| Retained Earnings | -$17.86M | -$15.43M | -$11.11M | -$9.02M | -$5.10M | -$2.93M |
| **Total Stockholders' Equity** | -$2.30M | -$1.46M | -$1.41M | -$1.07M | -$465K | -$80K |
| Total Equity | -$2.30M | -$1.46M | -$1.41M | -$1.07M | -$465K | -$80K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5 | $27K | $180 | $15K | $92 | $839 | $3.7K | $6.1K |
| **Cash & Short-Term Investments** | $5 | $27K | $180 | $15K | $92 | $839 | $3.7K | $6.1K |
| **Total Current Assets** | $5 | $27K | $180 | $15K | $92 | $839 | $3.7K | $6.1K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $31 | $56 |
| **Total Non-Current Assets** | $4.3K | $5.0K | $5.6K | $6.3K | $6.9K | $7.5K | $8.2K | $8.9K |
| **Total Assets** | $4.3K | $32K | $5.8K | $21K | $7.0K | $8.4K | $12K | $15K |
| **Total Current Liabilities** | $2.03M | $2.67M | $2.56M | $2.32M | $2.17M | $1.98M | $1.67M | $1.47M |
| **Total Non-Current Liabilities** | $2.3K | $2.7K | $3.2K | $3.7K | $6.0K | $6.2K | $6.4K | $6.5K |
| **Total Liabilities** | $2.03M | $2.67M | $2.56M | $2.32M | $2.18M | $1.99M | $1.68M | $1.48M |
| **Total Debt (incl. Leases)** | $5.1K | $5.6K | $6.1K | $6.5K | $6.0K | $7.2K | $7.4K | $7.5K |
| Common Stock | $1.9K | $1.9K | $1.9K | $1.9K | $1.9K | $1.9K | $1.9K | $1.9K |
| Retained Earnings | -$19.19M | -$18.76M | -$18.45M | -$17.86M | -$17.24M | -$16.67M | -$16.02M | -$15.43M |
| **Total Stockholders' Equity** | -$2.03M | -$2.64M | -$2.56M | -$2.30M | -$2.17M | -$1.98M | -$1.67M | -$1.46M |
| Total Equity | -$2.03M | -$2.64M | -$2.56M | -$2.30M | -$2.17M | -$1.98M | -$1.67M | -$1.46M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.43M | -$4.32M | -$2.09M | -$3.91M | -$2.18M | -$2.08M |
| Depreciation & Amortization | $56 | $100 | $100 | $51 | -- | -- |
| Stock-Based Compensation | $1.04M | $2.61M | $664K | $259K | $308K | $220K |
| **Operating Cash Flow** | -$558K | -$742K | -$452K | -$199K | -$1.17M | -$1.42M |
| Common Stock Issued | $398K | $503K | -- | $60K | $1.08M | $1.40M |
| **Financing Cash Flow** | $567K | $748K | $452K | $195K | $1.17M | $1.37M |
| **Net Change in Cash** | $8.7K | $6.1K | -$38 | -$4.9K | $2.7K | -$52K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$433K | -$307K | -$590K | -$623K | -$569K | -$649K | -$587K | -$867K |
| Depreciation & Amortization | -- | -- | -- | $0 | $0 | $31 | $25 | $25 |
| Stock-Based Compensation | $45K | $25K | $210K | $281K | $277K | $250K | $232K | $370K |
| **Operating Cash Flow** | -$82K | -$137K | -$109K | -$128K | -$104K | -$139K | -$187K | -$186K |
| **Financing Cash Flow** | $55K | $164K | $95K | $143K | $103K | $136K | $185K | $113K |
| **Net Change in Cash** | -$27K | $27K | -$15K | $15K | -$747 | -$2.9K | -$2.3K | -$73K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -11542.2% | -28909.6% | -1340313.5% | -1331289.1% | -44052.8% | -3402.4% |
| Current Ratio | 0.01x | 0.00x | 0.00x | -- | -- | -- |
| Quick Ratio | 0.01x | 0.00x | 0.00x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -44961.8% | -6487.1% | -41891.9% | -11542.2% | -38173.0% | -32761.0% | -23151.5% | -28909.6% |
| Current Ratio | 0.00x | 0.01x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x |
| Quick Ratio | 0.00x | 0.01x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
